Mitapivat
Back to searchMolecule Structure
Scientific Name
Mitapivat
Description of the Drug
Mitapivat is a pyruvate kinase activator used to treat hemolytic anemia in adults with pyruvate kinase (PK) deficiency.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB16236
http://www.drugbank.ca/drugs/DB16236
Brand Name(s)
Not Available
Company Owner(s)
Agios Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Pyruvate kinase isozymes R/L | SINGLE PROTEIN | ACTIVATOR | CHEMBL1075126 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL2702716 |
PharmGKB | PA166278021 |
DrugBank | DB16236 |
PubChem: Thomson Pharma | 163433338 |
PubChem | 59634741 |
ChemicalBook | CB72736694 |
Guide to Pharmacology | 10473 |
ZINC | ZINC000140430983 |